Persistent Cardiac Troponin I Elevation in Stabilized Patients After an Episode of Acute Coronary Syndrome Predicts Long-Term Mortality

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Circulation

• Publication date

  2007-10-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.107.708529PMID 17909103
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term health outcomes associated with detectable troponin I concentrations.

  2007cited by this paper
• 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study.

  2006cited by this paper
• Prevalence and Determinants of Troponin T Elevation in the General Population

  2006cited by this paper
• Troponin I as a Predictor of Coronary Heart Disease and Mortality in 70-Year-Old Men

  2006cited by this paper
• Troponin I as a Predictor of Coronary Heart Disease and Mortality in 70-Year-Old Men: A Community-Based Cohort Study

  2006cited by this paper
• A model for troponin I as a quantitative predictor of in-hospital mortality.

  2006cited by this paper
• Narrative Review: Alternative Causes for Elevated Cardiac Troponin Levels when Acute Coronary Syndromes Are Excluded

  2005cited by this paper
• Implication of different cardiac troponin I levels for clinical outcomes and prognosis of acute chest pain patients.

  2004cited by this paper
• Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction.

  2004cited by this paper
• Ongoing Myocardial Injury in Stable Severe Heart Failure: Value of Cardiac Troponin T Monitoring for High-Risk Patient Identification

  2004cited by this paper
• Troponin-I elevation in patients with increased left ventricular mass.

  2003cited by this paper
• Cardiac Troponin I Is Associated With Impaired Hemodynamics, Progressive Left Ventricular Dysfunction, and Increased Mortality Rates in Advanced Heart Failure

  2003cited by this paper
• European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials.

  2002cited by this paper
• Multicenter evaluation of an automated assay for troponin I.

  2002cited by this paper
• Comparison of Plasma Cardiac Troponins T and I in Chronically Hemodialyzed Patients in Relation to Cardiac Status and Age

  2002cited by this paper
• Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.

  2002cited by this paper
• Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats.

  2001cited by this paper
• A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden.

  2001cited by this paper
• Extensive Troponin I and T Modification Detected in Serum From Patients With Acute Myocardial Infarction

  2000cited by this paper
• CARDIAC-SPECIFIC TROPONIN I LEVELS TO PREDICT THE RISK OF MORTALITY IN PATIENTS WITH ACUTE CORONARY SYNDROMES

  2000cited by this paper
• Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction.

  2000cited by this paper
• Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart.

  2000cited by this paper
• Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study

  1999cited by this paper
• Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators.

  1999cited by this paper
• Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM Study Group. Thrombin Inhibition in Myocardial ischemia.

  1997cited by this paper
• Relation Between Troponin T and the Risk of Subsequent Cardiac Events in Unstable Coronary Artery Disease

  1996cited by this paper
• Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group.

  1996cited by this paper
• Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.

  1996cited by this paper

• Sex-based differences in biomarker trajectories in acute coronary syndrome patients from the BIOMArCS study

  2025cites this paper
• Saudi Heart Association Position Statement on Troponin use for Cardiovascular Risk Screening in Asymptomatic Populations

  2025cites this paper
• The Clinical Significance of miR-139-5p in Acute Coronary Syndrome and its Potential Effect on the Progression of Acute Coronary Syndrome

  2025cites this paper
• Acute Coronary Syndrome Subphenotypes Based on Repeated Biomarker Measurements in Relation to Long‐Term Mortality Risk

  2024cites this paper
• Advancements in electrochemical immunosensors towards point-of-care detection of cardiac biomarkers.

  2024cites this paper
• Cardiac Biomarker Responses Following High-Intensity Interval and Continuous Exercise: The Influence of ACE-I/D Gene Polymorphism and Training Status in Men.

  2024cites this paper
• High-sensitivity Cardiac Troponin in Stable Atherosclerotic Vascular Disease.

  2023cites this paper
• Circulating Blood-Based Biomarkers in Pulmonary Hypertension

  2022cites this paper
• Association of Serial High-Sensitivity Cardiac Troponin T With Subsequent Cardiovascular Events in Patients Stabilized After Acute Coronary Syndrome: A Secondary Analysis From IMPROVE-IT.

  2022cites this paper
• Exploration of serum cardiac troponin I as a biomarker of cardiomyopathy in southern sea otters (Enhydra lutris nereis).

  2021cites this paper
• Injectable conductive gelatin methacrylate / oxidized dextran hydrogel encapsulating umbilical cord mesenchymal stem cells for myocardial infarction treatment

  2021cites this paper
• Machine learning-based in-hospital mortality prediction models for patients with acute coronary syndrome.

  2020cites this paper
• Temporal Evolution of Serum Concentrations of High‐Sensitivity Cardiac Troponin During 1 Year After Acute Coronary Syndrome Admission

  2020cites this paper
• Redefining the Prognostic Value of High-Sensitivity Troponin in COVID-19 Patients: The Importance of Concomitant Coronary Artery Disease

  2020cites this paper
• Acute Responses of Cardiac Biomarkers to Intermittent and Continuous Exercise Are Related to Age Difference but Not I/D Polymorphism in the ACE Gene

  2020cites this paper
• Cardiac troponins predict adverse clinical outcomes in stable coronary artery disease: a dose–response meta-analysis of prospective studies

  2019influential citation
• ST-segment elevation myocardial infarction

  2019cites this paper
• Elevated High-Sensitivity Troponin I in the Stabilized Phase after an Acute Coronary Syndrome Predicts All-Cause and Cardiovascular Mortality in a Highly Admixed Population: A 7-Year Cohort

  2019cites this paper
• Prognostic Value of a Novel and Established High-Sensitivity Troponin I Assay in Patients Presenting with Suspected Myocardial Infarction

  2019cites this paper
• High-sensitivity troponin I and all-cause mortality in patients with stable COPD: an analysis of the COSYCONET study

  2019cites this paper
• Validation de modalités d’imagerie innovantes de l’athérosclérose par cathéter intravasculaire bimodal combinant fluorescence (NIRF) et ultrasons (IVUS) couplé à l’injection locale de sondes moléculaires in vivo ciblant ICAM-1 et le collagène

  2019cites this paper
• Role of Early Pharmacoinvasive Strategy in Management of Patients with Acute ST Elevation Myocardial Infarction

  2019cites this paper
• Spinal NGF induces anti‐intrathecal opioid‐initiated cardioprotective effect via regulation of TRPV1 expression

  2019cites this paper
• High-Sensitivity Troponin I in Atrial Fibrillation: Impact of rate and rhythm control and associations with biomarkers related to atrial fibrillation pathophysiology

  2018cites this paper
• Performance of Coronary Risk Scores Among Patients With Chest Pain in the Emergency Department.

  2018cites this paper
• Effect of Acute Coronary Syndrome Probability on Diagnostic and Prognostic Performance of High-Sensitivity Cardiac Troponin.

  2018cites this paper
• Multi-Center Study of the 99th Percentile Value of High-Sensitivity Troponin I in A Normal Healthy Chinese Population

  2017cites this paper
• Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction: Findings From the American Heart Association Get With The Guidelines–Heart Failure Program

  2017cites this paper
• High Sensitivity Troponins Discriminate Different Morphologies of Coronary Artery Plaques Being Assessed by Coronary Computed Tomography Angiography

  2017cites this paper
• Biomarkers in Stable Coronary Artery Disease.

  2017cites this paper
• Stable High-Sensitivity Cardiac Troponin T Levels and Outcomes in Patients With Chest Pain.

  2017cites this paper
• Serum Troponin I levels among hypertensive Military Service Personnel at a Military Health Facility in Abuja, Nigeria.

  2017cites this paper
• Comparative analysis of high-sensitivity cardiac troponin I and T for their association with coronary computed tomography-assessed calcium scoring represented by the Agatston score

  2017cites this paper
• Biomarker release after percutaneous coronary intervention in patients without established myocardial infarction as assessed by cardiac magnetic resonance with late gadolinium enhancement

  2017cites this paper
• Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time

  2017cites this paper
• Cardiac troponin I release after a basketball match in elite, amateur and junior players

  2016cites this paper
• Unrecognized myocardial infarction and cardiac biochemical markers in patients with stable coronary artery disease

  2016cites this paper
• Liberação de biomarcadores de necrose miocárdica após angioplastia coronária percutânea em ausência de infarto do miocárdio manifesto: estudo com ressonância nuclear magnética

  2016cites this paper
• Troponin I levels in permanent atrial fibrillation—impact of rate control and exercise testing

  2016cites this paper
• The prognostic value of acute and chronic troponin elevation after transcatheter aortic valve implantation.

  2016cites this paper
• Unrecognized myocardial infarctions detected by cardiac magnetic resonance imaging are associated with cardiac troponin I levels.

  2016cites this paper
• Novel aspects of cardiovascular biomarkers in myocardial infarction and obstructive sleep apnea

  2015cites this paper
• Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

  2015cites this paper
• Hochsensitives Troponin in Diagnostik, Risikostratifizierung und Prognose bei Patienten mit akuten kardiovaskulären Erkrankungen in der Notaufnahme

  2015cites this paper
• Optimal Cutoff Levels of More Sensitive Cardiac Troponin Assays for the Early Diagnosis of Myocardial Infarction in Patients With Renal Dysfunction

  2015cites this paper
• Use of a high‐sensitivity troponin T assay in the assessment and disposition of patients attending a tertiary Australian emergency department: A cross‐sectional pilot study

  2015cites this paper
• Individual variability in cardiac biomarker release after 30 min of high-intensity rowing in elite and amateur athletes.

  2015cites this paper
• The Prognostic Value of High-Sensitive Troponin I in Stable Coronary Artery Disease Depends on Age and Other Clinical Variables

  2015cites this paper
• Tutorial I – Case Study: Detection of Stress-Induced Ischemia in Patients with Chest Pain After “Rule-Out ACS” Protocol

  2015cites this paper
• Troponins and other biomarkers in the early diagnosis of acute myocardial infarction

  2015cites this paper
• Biomarkers in Cardiology - Part 2: In Coronary Heart Disease, Valve Disease and Special Situations

  2015cites this paper
• Applying a Big Data Approach to Biomarker Discovery: Running Before We Walk?

  2015cites this paper
• Lessons from the heart: troponin elevations in patients with established peripheral artery disease.

  2014cites this paper
• Cardiac troponin I levels in patients with non-ST-elevation acute coronary syndrome-the importance of gender.

  2014cites this paper
• Cardiac Troponin Specific Autoantibodies: Analytical Tools for Exploring Their Impact on Cardiac Troponin I Testing

  2014cites this paper
• Study design of embracing high-sensitivity troponin effectively: the value of more information: a randomized comparison.

  2014cites this paper
• Novel sensitive cardiac troponin I immunoassay free from troponin I-specific autoantibody interference

  2014cites this paper
• Importance of persistent elevation of cardiac biomarkers in atrial fibrillation: a RE-LY substudy

  2014cites this paper
• Enhanced sensitivity and multiplexing with 2D LC/MRM-MS and labeled standards for deeper and more comprehensive protein quantitation.

  2014cites this paper
• Association between Cardiac Troponin Level and Coronary Flow Reserve in Patients without Coronary Artery Disease: Insight from a Thermodilution Technique Using an Intracoronary Pressure Wire

  2014cites this paper
• Diagnostic Accuracy of a New Cardiac Electrical Biomarker for Detection of Electrocardiogram Changes Suggestive of Acute Myocardial Ischemic Injury

  2013cites this paper
• Acute coronary syndrome – the present and future role of biomarkers 1 )

  2013cites this paper
• Cardiac troponin I levels measured with a high-sensitive assay increase over time and are strong predictors of mortality in an elderly population.

  2013cites this paper
• Hospital laboratory reporting may be a barrier to detection of ‘microsize’ myocardial infarction in the US: an observational study

  2013cites this paper
• New Risk Markers in Atrial Fibrillation

  2013cites this paper
• Cardiomyocyte injury assessed by a highly sensitive troponin assay and sudden cardiac death in the community: the Cardiovascular Health Study.

  2013cites this paper
• Cardiac troponin assay classification by both clinical and analytical performance characteristics: a study on outcome prediction.

  2013cites this paper
• Measurement of heart-type fatty acid-binding protein before discharge.

  2013cites this paper
• Troponin: messenger or actor?

  2013cites this paper
• Disease distribution and outcome in troponin-positive patients with or without revascularization in a chest pain unit: results of the German CPU-Registry

  2013cites this paper
• Using high-sensitivity troponin T: the importance of the proper gold standard.

  2013cites this paper
• Evaluation of four sensitive troponin assays for risk assessment in acute coronary syndromes using a new clinically oriented approach for comparison of assays

  2013cites this paper
• Acute coronary syndrome – the present and future role of biomarkers1)

  2013cites this paper
• Association of cardiac troponin I with disease severity and outcomes in patients with pulmonary hypertension.

  2013cites this paper
• Early diagnosis of acute myocardial infarction in patients with pre-existing coronary artery disease using more sensitive cardiac troponin assays.

  2012cites this paper
• Clinically Unrecognized Myocardial Scars Detected by MRI

  2012cites this paper
• RETRACTED ARTICLE: Concomitant measurement of copeptin and high-sensitivity troponin for fast and reliable rule out of acute myocardial infarction

  2012cites this paper
• Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section.

  2012cites this paper
• A novel technology for measuring cumulative cardiac biomarker exposure over time: what happened when we weren't looking?

  2012cites this paper
• Darapladib effect on circulating high sensitive troponin in patients with acute coronary syndromes.

  2012cites this paper
• Serial Measurement of Cardiac Troponin T Using a Highly Sensitive Assay in Patients With Chronic Heart Failure: Data From 2 Large Randomized Clinical Trials

  2012cites this paper
• High-sensitive Troponin I in acute cardiac conditions: implications of baseline and sequential measurements for diagnosis of myocardial infarction.

  2012cites this paper
• Highly sensitive troponin immunoassays: navigating between the scylla and charybdis.

  2012cites this paper
• High sensitive troponin T in individuals with chest pain of presumed ischemic origin.

  2012cites this paper
• Identification of troponin determinants for improving its diagnostic performance in the emergency department.

  2012cites this paper
• Developing and assessing cardiovascular biomarkers.

  2012cites this paper
• Towards appreciating appropriate clinical responses to highly sensitive cardiac troponin assays

  2012cites this paper
• Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation: A Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Substudy

  2012cites this paper
• Determinants of high-sensitivity troponin T among patients with a noncardiac cause of chest pain.

  2012cites this paper
• Evaluation eines ultrasensitiven Troponin-I Assays als Screening-Test und zur Unterscheidung verschiedener Schweregrade der felinen hypertrophen Kardiomyopathie

  2012cites this paper
• Cardiac troponin and heart failure in the era of high-sensitivity assays.

  2012cites this paper
• Retraction of “Concomitant measurement of copeptin and high-sensitivity troponin for fast and reliable rule out of acute myocardial infarction”

  2012cites this paper
• Acute Coronary Syndrome Prognostic Value of Biomarkers During and After NonST-Segment Elevation

  2011cites this paper
• Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin.

  2011cites this paper
• High-sensitive troponin T and I are related to invasive hemodynamic data and mortality in patients with left-ventricular dysfunction and precapillary pulmonary hypertension.

  2011cites this paper
• La inmunoadsorción: ¿alternativa o adyuvante del tratamiento quirúrgico?

  2011cites this paper
• Serum High-Sensitivity Cardiac Troponin T Is a Significant Biomarker of Left-Ventricular Diastolic Dysfunction in Subjects with Non-Diabetic Chronic Kidney Disease

  2011cites this paper
• High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population.

  2011cites this paper
• Cardiac Biomarker Response to Intermittent Exercise Bouts

  2011cites this paper
• Myocardial regeneration in heart failure: integrated development of biological therapeutic approaches

  2011cites this paper